Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.

Ontario is proposing to further expand pharmacists' scope of practice by adding to the list of minor ailments they can assess, allowing them to administer more vaccines and order some lab tests.

So you think about the number of infants that are born every year you're playing the long game, the bulk of the 120 million that are ... beyond KEYTRUDA. And in vaccines, broadening beyond GARDASIL, ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last year — could have an unprecedented impact keeping infants out of ...

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...

COVID-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.